Table 3.
Individual subject results from Study 2.
| Subject | Observed Emax Values | Normalized Emax Values | ||
|---|---|---|---|---|
| Clobetasol Propionate (2) |
Fluocinolone Acetonide |
Clobetasol Propionate (2) |
Fluocinolone Acetonide |
|
| 1 | −56.98 | −59.20 | −72.37 | −74.59 |
| 2 | −88.12 | −66.48 | −103.51 | −81.87 |
| 3 | −39.75 | −58.76 | −55.13 | −74.15 |
| 4 | −68.04 | −63.66 | −83.43 | −79.05 |
| 5 | −62.63 | −59.23 | −78.02 | −74.62 |
| 6 | −56.50 | −55.39 | −71.89 | −70.78 |
| 7 | −68.51 | −73.88 | −83.90 | −89.27 |
| 8 | −58.31 | −59.44 | −73.70 | −74.83 |
| 9 | −56.13 | −71.39 | −71.52 | −86.78 |
| 10 | −45.52 | −60.98 | −60.91 | −76.37 |